Systematic investigation of the pharmacological mechanism of Tanreqing injection in treating respiratory diseases by UHPLC/Q-TOF-MS/MS based on multiple in-house chemical libraries coupled with network pharmacology

Wang, Liang; Ma, Ying; He, Yu-Qiong; Deng, Jiaming; Huang, Doudou; Zhang, Xiaoli; Chen, Kaixian; Qiu, Shi; Chen, Wansheng

doi:10.1016/j.jpba.2021.114141

Cited by 10 publications

(7 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, this method is largely controversial. There is no standard for threshold setting from the current network analysis, and many methods are adopted, such as selecting the top 3 [ 108 ] or top 10 [ 109 , 110 ] of the degree value directly; Or combining topological parameters such as degree, Betweenness Centrality, and Closeness Centrality [ 111 , 112 ]. In addition, it was found that only Glycyrrhizin has been confirmed to exist in LHQW through literature mining [ 113 – 116 ], which shows that the screening results need further compound verification.…”

Section: Resultsmentioning

confidence: 99%

Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19

Liang

et al. 2022

Chin Med

View full text Add to dashboard Cite

Background Lianhua Qingwen Capsules (LHQW) is a traditional Chinese medicine prescription commonly used to treat viral influenza in China. There has been sufficient evidence that LHQW could effectively treat COVID-19. Nevertheless, the potential anti-(mutant) SARS-CoV-2 and anti-inflammation compounds in LHQW are still vague. Methods The compounds of LHQW and targets were collected from TCMSP, TCMID, Shanghai Institute of Organic Chemistry of CAS database, and relevant literature. Autodock Vina was used to carry out molecular docking. The pkCSM platform to predict the relevant parameters of compound absorption in vivo. The protein–protein interaction (PPI) network was constructed by the STRING database. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis was carried out by Database for Annotation, Visualization, and Integrated Discovery (DAVID). The anti-(mutant) SARS-CoV-2 and anti-inflammation networks were constructed on the Cytoscape platform. Results 280 compounds, 16 targets related to SARS-CoV-2, and 54 targets related to cytokine storm were obtained by screening. The key pathways Toll-like receptor signaling, NOD-like receptor signal pathway, and Jak-STAT signaling pathway, and the core targets IL6 were obtained by PPI network and KEGG pathway enrichment analysis. The network analysis predicted and discussed the 16 main anti-SARS-CoV-2 active compounds and 12 main anti-inflammation active compounds. Ochnaflavone and Hypericin are potential anti-mutant virus compounds in LHQW. Conclusions In summary, this study explored the potential anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of LHQW against COVID-19, which can provide new ideas and valuable references for discovering active compounds in the treatment of COVID-19.

show abstract

Section: Resultsmentioning

confidence: 99%

Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19

Liang

et al. 2022

Chin Med

View full text Add to dashboard Cite

show abstract

“…Referring to domestic and foreign literature to identify the active ingredients and the content of the main ingredients of TRQI [ 13 , 26 , 52 , 63 ], the four main ingredients, baicalin, ursodeoxycholic acid, chenodeoxycholic acid, and chlorogenic acid were selected [ 52 , 63 ] and the information related to the ingredients was retrieved from the TCMSP ( http://tcmspw.com/ ) database [ 45 ] to obtain their unique Mol IDs (Table S2).…”

Section: Methodsmentioning

confidence: 99%

Efficacy evaluation and potential pharmacological mechanism of tanreqing injection in the treatment of COPD combined with respiratory failure based on meta-analysis and network pharmacology

Wang¹,

Han²,

Huang³

et al. 2023

Heliyon

View full text Add to dashboard Cite

“…It has signi cant anti-in ammatory, antiviral, antibacterial, and immunomodulatory activity, among other effects, and is widely used in the treatment of respiratory diseases [6,7] . Baicalin, ursodeoxycholic acid, chenodeoxycholic acid, and chlorogenic acid are its main active ingredients [8,9] . Baicalin shows characteristics associated with gastrointestinal hydrolysis, enterohepatic circulation, carrier transport, and complex metabolism, and baicalin can be converted into baicalein during the absorption process, the latter of which has antitumor, antibacterial, antioxidant, and some other pharmacological activities [10,11] .…”

Section: Introductionmentioning

confidence: 99%

Pharmacokinetic Study of the Main Components of Tanreqing Capsules and Tanreqing Injections in beagles by liquid chromatography–tandem mass spectrometry

Wang

et al. 2022

Preprint

Self Cite

View full text Add to dashboard Cite

Background Tanreqing capsules (TRQCs) and Tanreqing injections (TRQIs) are traditional Chinese medicine compound preparations that are widely used in the treatment of respiratory diseases. Although the ingredients of the two formulations are the same, differences in the way they are metabolized may affect their relative efficacy. In this study, a simple, rapid, and sensitive liquid chromatography–tandem mass spectrometry (LC-MS/MS) method was developed for simultaneous quantification of the main components of Tanreqing, which include chlorogenic acid, ursodeoxycholic acid, chenodeoxycholic acid, and baicalin, in beagle dog plasma to compare the pharmacokinetic parameters resulting from TRQI and TRQC administration. Method Plasma samples were pretreated with protein precipitation. Chromatographic separation was performed on a Waters Acquity UPLC HSS T3 (2.1 × 100 mm, 1.8 µm) column using a gradient elution with (A) 0.1% (v/v) formic acid aqueous solution and (B) acetonitrile. Six healthy beagles were divided into two groups, and a crossover, comparative pharmacokinetic study of TRQC (0.09g/kg) and TRQI (0.5 mL/kg) after a single-dose administration or daily doses over 7 days was carried out. One group was administrated a single dose of TRQC and followed continuously for 7 days, whereas the other group was treated with TRQI in the same way. Results The major pharmacokinetic parameters of the four compounds were not significantly different between the two formulations (P > 0.05). Conclusions The measured levels of the four major components of TRQCs and TRQIs were consistent in these dogs, providing a reference for the clinical application of TRQCs instead of TRQIs.

show abstract

Systematic investigation of the pharmacological mechanism of Tanreqing injection in treating respiratory diseases by UHPLC/Q-TOF-MS/MS based on multiple in-house chemical libraries coupled with network pharmacology

Cited by 10 publications

References 29 publications

Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19

Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19

Efficacy evaluation and potential pharmacological mechanism of tanreqing injection in the treatment of COPD combined with respiratory failure based on meta-analysis and network pharmacology

Pharmacokinetic Study of the Main Components of Tanreqing Capsules and Tanreqing Injections in beagles by liquid chromatography–tandem mass spectrometry

Contact Info

Product

Resources

About